Company overview
MGI Tech is a leading Chinese biotechnology company specializing in high-throughput DNA sequencers, multi-omics platforms, and lab automation systems for life sciences and healthcare. The company manufactures clinical-grade gene sequencers using DNA nanoball sequencing technology, offering solutions for genomic research, precision medicine, and genetic testing with industry-leading throughput and cost-effectiveness. MGI serves over 3,560 users across 5,300 installations globally, providing comprehensive workflows from sample preparation through bioinformatics analysis.
MGI Tech is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include dna sequencing, gene sequencer, high-throughput sequencing, genomics, multi-omics.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://global-mgitech.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- dna sequencing, gene sequencer, high-throughput sequencing, genomics, multi-omics
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What sequencing technologies does MGI offer?
- MGI manufactures high-throughput DNA sequencers based on DNA nanoball sequencing technology. Current flagship models include the DNBSEQ-T7+, which delivers over 14 Tb/day of data and can sequence 144 human genomes daily, and the DNBSEQ-T20, capable of reading up to 50,000 human genomes annually at approximately $100 per genome.
- What is MGI's global market presence?
- MGI Tech serves over 3,560 users with 5,300 installations across six continents. The company provides sequencing platforms, consumables, bioinformatics software, and genetic testing services to research institutions, hospitals, and enterprises worldwide.
- What end-to-end solutions does MGI provide for genomic workflows?
- MGI offers comprehensive genomic solutions spanning sample preparation, sequencing, data analysis, and bioinformatics. The company provides integrated platforms combining its DNBSEQ sequencers with automation systems and AI-powered analysis tools through partnerships, enabling complete workflow automation from sample to results.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
